O	0	1	3	3	CD	B-NP
O	1	2	.	.	.	I-NP
O	2	3	2	2	CD	I-NP
O	3	4	.	.	.	O

O	5	14	Molecular	Molecular	JJ	B-NP
O	15	25	Mechanisms	Mechanism	NNS	I-NP
O	26	35	Mediating	Mediate	VBG	B-VP
O	36	39	the	the	DT	B-NP
O	40	49	Perinatal	Perinatal	JJ	I-NP
B-Cell	50	54	Beta	Beta	NN	I-NP
I-Cell	54	55	-	-	HYPH	B-NP
I-Cell	55	59	Cell	Cell	NN	I-NP
O	60	68	Adaptive	Adaptive	JJ	I-NP
O	69	77	Response	Response	NN	I-NP
O	78	80	to	to	TO	B-PP
O	81	86	Early	Early	RB	B-NP
O	86	87	-	-	HYPH	I-NP
O	87	91	Life	Life	NN	I-NP
O	92	101	Stressors	Stressor	NNS	I-NP

O	102	111	Molecular	Molecular	JJ	B-NP
O	112	122	mechanisms	mechanism	NNS	I-NP
O	123	134	responsible	responsible	JJ	B-ADJP
O	135	138	for	for	IN	B-PP
O	139	147	impaired	impaired	JJ	B-NP
B-Cell	148	152	beta	beta	SYM	I-NP
I-Cell	152	153	-	-	HYPH	I-NP
I-Cell	153	157	cell	cell	NN	I-NP
O	158	162	mass	mass	NN	I-NP
O	163	172	formation	formation	NN	I-NP
O	173	178	after	after	IN	B-PP
O	179	183	IUCR	IUCR	NN	B-NP
O	184	186	or	or	CC	I-NP
O	187	191	IUPR	IUPR	NN	I-NP
O	192	196	have	have	VBP	B-VP
O	197	201	come	come	VBN	I-VP
O	202	207	under	under	IN	B-PP
O	208	221	investigation	investigation	NN	B-NP
O	221	222	.	.	.	O

O	223	228	First	First	RB	B-ADVP
O	228	229	,	,	,	O
O	230	232	it	it	PRP	B-NP
O	233	236	has	have	VBZ	B-VP
O	237	241	been	be	VBN	I-VP
O	242	250	proposed	propose	VBN	I-VP
O	251	255	that	that	IN	B-SBAR
O	256	260	IUCR	IUCR	NN	B-NP
O	261	264	can	can	MD	B-VP
O	265	271	result	result	VB	I-VP
O	272	274	in	in	IN	B-PP
O	275	276	a	a	DT	B-NP
O	277	286	reduction	reduction	NN	I-NP
O	287	289	of	of	IN	B-PP
O	290	293	the	the	DT	B-NP
B-Cell	294	303	embryonic	embryonic	JJ	I-NP
I-Cell	304	308	beta	beta	SYM	I-NP
I-Cell	308	309	-	-	HYPH	I-NP
I-Cell	309	313	cell	cell	NN	I-NP
I-Cell	314	324	progenitor	progenitor	NN	I-NP
I-Cell	325	329	pool	pool	NN	I-NP
O	330	337	leading	lead	VBG	B-VP
O	338	340	to	to	TO	I-VP
O	341	354	inappropriate	inappropriate	VB	I-VP
O	355	364	postnatal	postnatal	JJ	B-NP
B-Cell	365	369	beta	beta	SYM	I-NP
I-Cell	369	370	-	-	HYPH	I-NP
I-Cell	370	374	cell	cell	NN	I-NP
O	375	384	formation	formation	NN	I-NP
O	384	385	.	.	.	O

O	386	393	Stanger	Stanger	NNP	B-NP
O	394	396	et	et	FW	I-NP
O	397	399	al	al	FW	I-NP
O	399	400	.	.	.	O

O	401	402	[	[	(	O
O	402	405	108	108	CD	B-NP
O	405	406	]	]	)	O
O	407	419	demonstrated	demonstrate	VBD	B-VP
O	420	424	that	that	IN	B-SBAR
O	425	434	selective	selective	JJ	B-NP
O	435	442	genetic	genetic	JJ	I-NP
O	443	452	reduction	reduction	NN	I-NP
O	453	455	in	in	IN	B-PP
O	456	459	the	the	DT	B-NP
O	460	464	size	size	NN	I-NP
O	465	467	of	of	IN	B-PP
O	468	471	PDX	PDX	NN	B-NP
O	471	472	-	-	HYPH	B-NP
O	472	473	1	1	CD	I-NP
O	473	474	+	+	SYM	I-NP
B-Cell	475	485	pancreatic	pancreatic	JJ	I-NP
I-Cell	486	497	progenitors	progenitor	NNS	I-NP
O	498	504	during	during	IN	B-PP
O	505	508	the	the	DT	B-NP
B-Developing_anatomical_structure	509	514	fetal	fetal	JJ	I-NP
O	515	521	period	period	NN	I-NP
O	522	529	results	result	VBZ	B-VP
O	530	532	in	in	IN	B-PP
O	533	541	impaired	impaired	JJ	B-NP
B-Cell	542	546	beta	beta	SYM	I-NP
I-Cell	546	547	-	-	HYPH	I-NP
I-Cell	547	551	cell	cell	NN	I-NP
O	552	561	formation	formation	NN	I-NP
O	562	568	during	during	IN	B-PP
O	569	572	the	the	DT	B-NP
O	573	582	postnatal	postnatal	JJ	I-NP
O	583	589	period	period	NN	I-NP
O	590	594	with	with	IN	B-PP
O	595	605	consequent	consequent	JJ	B-NP
O	606	617	development	development	NN	I-NP
O	618	620	of	of	IN	B-PP
O	621	628	glucose	glucose	NN	B-NP
O	629	640	intolerance	intolerance	NN	I-NP
O	641	647	during	during	IN	B-PP
O	648	657	adulthood	adulthood	NN	B-NP
O	657	658	.	.	.	O

O	659	669	Consistent	Consistent	JJ	B-ADJP
O	670	674	with	with	IN	B-PP
O	675	679	this	this	DT	B-NP
O	679	680	,	,	,	O
O	681	689	maternal	maternal	JJ	B-NP
O	690	694	food	food	NN	I-NP
O	695	706	restriction	restriction	NN	I-NP
O	707	712	leads	lead	VBZ	B-VP
O	713	715	to	to	TO	B-PP
O	716	727	significant	significant	JJ	B-NP
O	728	737	reduction	reduction	NN	I-NP
O	738	740	in	in	IN	B-PP
O	741	744	PDX	PDX	NN	B-NP
O	744	745	-	-	HYPH	B-NP
O	745	746	1	1	CD	I-NP
O	746	747	+	+	SYM	I-NP
O	748	751	and	and	CC	I-NP
O	752	762	neurogenin	neurogenin	NN	I-NP
O	762	763	-	-	HYPH	B-NP
O	763	764	3	3	CD	I-NP
O	764	765	+	+	SYM	I-NP
B-Cell	766	776	pancreatic	pancreatic	JJ	I-NP
I-Cell	777	787	precursors	precursor	NNS	I-NP
O	788	794	during	during	IN	B-PP
B-Developing_anatomical_structure	795	804	embryonic	embryonic	JJ	B-NP
O	805	816	development	development	NN	I-NP
O	817	819	in	in	IN	B-PP
O	820	824	rats	rat	NNS	B-NP
O	824	825	,	,	,	O
O	826	836	diminished	diminish	VBD	B-VP
O	837	846	postnatal	postnatal	JJ	B-NP
B-Cell	847	851	beta	beta	SYM	I-NP
I-Cell	851	852	-	-	HYPH	I-NP
I-Cell	852	856	cell	cell	NN	I-NP
O	857	866	formation	formation	NN	I-NP
O	866	867	,	,	,	O
O	868	871	and	and	CC	O
O	872	881	inability	inability	NN	B-NP
O	882	884	to	to	TO	B-VP
O	885	891	expand	expand	VB	I-VP
B-Cell	892	896	beta	beta	SYM	B-NP
I-Cell	896	897	-	-	HYPH	I-NP
I-Cell	897	901	cell	cell	NN	I-NP
O	902	906	mass	mass	NN	I-NP
O	907	909	in	in	IN	B-PP
O	910	918	response	response	NN	I-PP
O	919	921	to	to	TO	I-PP
O	922	931	pregnancy	pregnancy	NN	B-NP
O	932	933	[	[	(	O
O	933	935	47	47	CD	B-NP
O	935	936	,	,	,	I-NP
O	937	939	94	94	CD	I-NP
O	939	940	]	]	)	O
O	940	941	.	.	.	O

O	942	945	The	The	DT	B-NP
O	946	949	UPI	UPI	NNP	I-NP
O	950	955	model	model	NN	I-NP
O	956	958	is	be	VBZ	B-VP
O	959	963	also	also	RB	I-VP
O	964	977	characterized	characterize	VBN	I-VP
O	978	980	by	by	IN	B-PP
O	981	982	a	a	DT	B-NP
O	983	992	permanent	permanent	JJ	I-NP
O	993	1001	decrease	decrease	NN	I-NP
O	1002	1004	in	in	IN	B-PP
B-Multi-tissue_structure	1005	1010	islet	islet	NN	B-NP
O	1011	1014	PDX	PDX	NN	I-NP
O	1014	1015	-	-	HYPH	B-NP
O	1015	1016	1	1	CD	I-NP
O	1017	1021	mRNA	mRNA	NN	I-NP
O	1022	1032	expression	expression	NN	I-NP
O	1032	1033	.	.	.	O

O	1034	1038	This	This	DT	B-NP
O	1039	1047	decrease	decrease	NN	I-NP
O	1048	1051	has	have	VBZ	B-VP
O	1052	1060	recently	recently	RB	I-VP
O	1061	1065	been	be	VBN	I-VP
O	1066	1071	shown	show	VBN	I-VP
O	1072	1074	to	to	TO	I-VP
O	1075	1077	be	be	VB	I-VP
O	1078	1081	due	due	JJ	B-ADJP
O	1082	1084	to	to	TO	B-PP
O	1085	1096	progressive	progressive	JJ	B-NP
O	1097	1107	epigenetic	epigenetic	JJ	I-NP
O	1108	1117	silencing	silencing	NN	I-NP
O	1118	1120	of	of	IN	B-PP
O	1121	1124	the	the	DT	B-NP
O	1125	1129	Pdx1	Pdx1	NN	I-NP
O	1130	1134	gene	gene	NN	I-NP
O	1135	1140	locus	locus	NN	I-NP
O	1141	1150	secondary	secondary	JJ	B-ADJP
O	1151	1153	to	to	TO	B-PP
O	1154	1162	proximal	proximal	JJ	B-NP
O	1163	1171	promoter	promoter	NN	I-NP
O	1172	1183	methylation	methylation	NN	I-NP
O	1184	1185	[	[	(	O
O	1185	1187	69	69	CD	B-NP
O	1187	1188	,	,	,	I-NP
O	1189	1192	109	109	CD	I-NP
O	1192	1193	]	]	)	O
O	1193	1194	,	,	,	O
O	1195	1198	and	and	CC	O
O	1199	1201	it	it	PRP	B-NP
O	1202	1205	may	may	MD	B-VP
O	1206	1208	be	be	VB	I-VP
O	1209	1220	responsible	responsible	JJ	B-ADJP
O	1221	1224	for	for	IN	B-PP
O	1225	1228	the	the	DT	B-NP
O	1229	1238	decreased	decrease	VBN	I-NP
O	1239	1243	rate	rate	NN	I-NP
O	1244	1246	of	of	IN	B-PP
B-Cell	1247	1251	beta	beta	SYM	B-NP
I-Cell	1251	1252	-	-	HYPH	B-NP
I-Cell	1252	1256	cell	cell	NN	I-NP
O	1257	1268	replication	replication	NN	I-NP
O	1269	1272	and	and	CC	O
O	1273	1286	inappropriate	inappropriate	JJ	B-NP
O	1287	1296	postnatal	postnatal	JJ	I-NP
B-Cell	1297	1301	beta	beta	SYM	I-NP
I-Cell	1301	1302	-	-	HYPH	I-NP
I-Cell	1302	1306	cell	cell	NN	I-NP
O	1307	1311	mass	mass	NN	I-NP
O	1312	1323	development	development	NN	I-NP
O	1324	1325	[	[	(	O
O	1325	1327	69	69	CD	B-NP
O	1327	1328	,	,	,	I-NP
O	1329	1332	110	110	CD	I-NP
O	1332	1333	]	]	)	O
O	1333	1334	.	.	.	O

O	1335	1337	In	In	IN	B-PP
O	1338	1341	the	the	DT	B-NP
O	1342	1346	same	same	JJ	I-NP
O	1347	1350	way	way	NN	I-NP
O	1351	1353	of	of	IN	B-PP
O	1354	1362	thinking	thinking	NN	B-NP
O	1362	1363	,	,	,	O
O	1364	1371	studies	study	NNS	B-NP
O	1372	1376	have	have	VBP	B-VP
O	1377	1389	demonstrated	demonstrate	VBN	I-VP
O	1390	1394	that	that	IN	B-SBAR
O	1395	1398	the	the	DT	B-NP
O	1399	1410	maintenance	maintenance	NN	I-NP
O	1411	1413	of	of	IN	B-PP
O	1414	1424	methylated	methylate	VBN	B-NP
O	1425	1432	histone	histone	NN	I-NP
O	1433	1435	H3	H3	NN	I-NP
O	1436	1440	Lys4	Lys4	NN	I-NP
O	1441	1443	by	by	IN	B-PP
O	1444	1448	Set7	Set7	NN	B-NP
O	1448	1449	/	/	SYM	O
O	1449	1450	9	9	CD	B-NP
O	1450	1451	,	,	,	O
O	1452	1453	a	a	DT	B-NP
O	1454	1460	member	member	NN	I-NP
O	1461	1463	of	of	IN	B-PP
O	1464	1467	the	the	DT	B-NP
O	1468	1471	SET	SET	NN	I-NP
O	1472	1489	methyltransferase	methyltransferase	NN	I-NP
O	1490	1496	family	family	NN	I-NP
O	1496	1497	,	,	,	O
O	1498	1500	is	be	VBZ	B-VP
O	1501	1508	crucial	crucial	JJ	B-ADJP
O	1509	1511	to	to	TO	B-PP
O	1512	1516	Pdx1	Pdx1	NN	B-NP
O	1517	1525	activity	activity	NN	I-NP
O	1526	1528	in	in	IN	B-PP
B-Cell	1529	1533	beta	beta	SYM	B-NP
I-Cell	1533	1534	-	-	HYPH	O
I-Cell	1534	1538	cell	cell	NN	B-NP
I-Cell	1539	1544	lines	line	NNS	I-NP
O	1545	1546	[	[	(	O
O	1546	1549	111	111	CD	B-NP
O	1549	1550	-	-	HYPH	I-NP
O	1550	1553	113	113	CD	I-NP
O	1553	1554	]	]	)	O
O	1554	1555	.	.	.	O

O	1556	1560	This	This	DT	B-NP
O	1561	1564	led	lead	VBD	B-VP
O	1565	1567	to	to	TO	B-PP
O	1568	1571	the	the	DT	B-NP
O	1572	1582	hypothesis	hypothesis	NN	I-NP
O	1583	1587	that	that	IN	B-SBAR
O	1588	1592	Set7	Set7	NN	B-NP
O	1592	1593	/	/	SYM	B-VP
O	1593	1594	9	9	CD	B-NP
O	1595	1598	may	may	MD	B-VP
O	1599	1608	represent	represent	VB	I-VP
O	1609	1610	a	a	DT	B-NP
O	1611	1616	novel	novel	JJ	I-NP
O	1617	1626	chromatin	chromatin	NN	I-NP
O	1626	1627	-	-	HYPH	O
O	1627	1636	modifying	modify	VBG	B-VP
O	1637	1644	protein	protein	NN	B-NP
O	1645	1649	that	that	WDT	B-NP
O	1650	1659	functions	function	VBZ	B-VP
O	1660	1662	in	in	IN	B-PP
O	1663	1667	part	part	NN	B-NP
O	1668	1675	through	through	IN	B-PP
O	1676	1679	its	its	PRP$	B-NP
O	1680	1691	recruitment	recruitment	NN	I-NP
O	1692	1694	to	to	TO	B-PP
O	1695	1701	target	target	NN	B-NP
O	1702	1707	genes	gene	NNS	I-NP
O	1708	1710	by	by	IN	B-PP
B-Cell	1711	1715	cell	cell	NN	B-NP
O	1715	1716	-	-	HYPH	B-NP
O	1716	1724	specific	specific	JJ	I-NP
O	1725	1738	transcription	transcription	NN	I-NP
O	1739	1746	factors	factor	NNS	I-NP
O	1747	1751	such	such	JJ	B-PP
O	1752	1754	as	as	IN	I-PP
O	1755	1759	Pdx1	Pdx1	NN	B-NP
O	1759	1760	.	.	.	O

O	1761	1766	Since	Since	IN	B-PP
O	1767	1771	then	then	RB	B-NP
O	1771	1772	,	,	,	O
O	1773	1774	a	a	DT	B-NP
O	1775	1779	role	role	NN	I-NP
O	1780	1782	of	of	IN	B-PP
O	1783	1790	histone	histone	NN	B-NP
O	1791	1797	methyl	methyl	NN	I-NP
O	1798	1810	transferases	transferas	NNS	I-NP
O	1810	1811	,	,	,	O
O	1812	1824	particularly	particularly	RB	B-NP
O	1825	1829	set7	set7	NN	I-NP
O	1829	1830	,	,	,	O
O	1831	1834	has	have	VBZ	B-VP
O	1835	1839	also	also	RB	I-VP
O	1840	1844	been	be	VBN	I-VP
O	1845	1857	demonstrated	demonstrate	VBN	I-VP
O	1858	1860	in	in	IN	B-PP
O	1861	1864	the	the	DT	B-NP
O	1865	1874	sustained	sustained	JJ	I-NP
O	1875	1886	deleterious	deleterious	JJ	I-NP
O	1887	1894	effects	effect	NNS	I-NP
O	1895	1897	of	of	IN	B-PP
O	1898	1905	chronic	chronic	JJ	B-NP
O	1906	1919	hyperglycemia	hyperglycemia	NN	I-NP
O	1920	1922	on	on	IN	B-PP
O	1923	1928	human	human	JJ	B-NP
B-Cell	1929	1942	microvascular	microvascular	JJ	I-NP
I-Cell	1943	1954	endothelial	endothelial	JJ	I-NP
I-Cell	1955	1960	cells	cell	NNS	I-NP
O	1961	1962	[	[	(	O
O	1962	1965	114	114	CD	B-NP
O	1965	1966	]	]	)	O
O	1966	1967	.	.	.	O

O	1968	1972	Such	Such	PDT	B-NP
O	1973	1975	an	an	DT	I-NP
O	1976	1986	epigenetic	epigenetic	JJ	I-NP
O	1987	1993	change	change	NN	I-NP
O	1994	1999	could	could	MD	B-VP
O	2000	2011	potentially	potentially	RB	I-VP
O	2012	2014	be	be	VB	I-VP
O	2015	2023	involved	involve	VBN	I-VP
O	2024	2026	in	in	IN	B-PP
O	2027	2030	the	the	DT	B-NP
O	2031	2042	deleterious	deleterious	JJ	I-NP
O	2043	2049	effect	effect	NN	I-NP
O	2050	2052	of	of	IN	B-PP
O	2053	2057	high	high	JJ	B-NP
O	2058	2065	glucose	glucose	NN	I-NP
O	2066	2070	upon	upon	IN	B-PP
O	2071	2074	the	the	DT	B-NP
B-Organ	2075	2080	fetal	fetal	JJ	I-NP
I-Organ	2081	2089	pancreas	pancreas	NN	I-NP
O	2090	2092	in	in	IN	B-PP
O	2093	2096	the	the	DT	B-NP
O	2097	2101	IUED	IUED	JJ	I-NP
O	2102	2108	models	model	NNS	I-NP
O	2108	2109	.	.	.	O

O	2110	2117	Another	Another	DT	B-NP
O	2118	2127	mechanism	mechanism	NN	I-NP
O	2128	2136	proposed	propose	VBN	B-VP
O	2137	2139	to	to	TO	I-VP
O	2140	2147	explain	explain	VB	I-VP
O	2148	2155	reduced	reduce	VBN	I-VP
B-Cell	2156	2160	beta	beta	SYM	B-NP
I-Cell	2160	2161	-	-	HYPH	B-NP
I-Cell	2161	2165	cell	cell	NN	I-NP
O	2166	2175	formation	formation	NN	I-NP
O	2176	2181	after	after	IN	B-SBAR
O	2182	2186	IUCR	IUCR	NN	B-NP
O	2187	2189	is	be	VBZ	B-VP
O	2190	2197	related	related	JJ	B-ADJP
O	2198	2200	to	to	TO	B-PP
O	2201	2209	prenatal	prenatal	JJ	B-NP
O	2210	2224	glucocorticoid	glucocorticoid	NN	I-NP
O	2225	2233	exposure	exposure	NN	I-NP
O	2233	2234	.	.	.	O

O	2235	2249	Administration	Administration	NN	B-NP
O	2250	2252	of	of	IN	B-PP
O	2253	2259	either	either	CC	O
O	2260	2273	dexamethasone	dexamethasone	NN	B-NP
O	2274	2276	or	or	CC	O
O	2277	2290	carbenoxolone	carbenoxolone	NN	B-NP
O	2291	2292	(	(	(	O
O	2292	2294	to	to	TO	B-VP
O	2295	2302	inhibit	inhibit	VB	I-VP
O	2303	2305	11	11	CD	B-NP
O	2306	2310	beta	beta	SYM	B-NP
O	2310	2311	-	-	HYPH	I-NP
O	2311	2325	hydroxysteroid	hydroxysteroid	NN	I-NP
O	2326	2339	dehydrogenase	dehydrogenase	NN	I-NP
O	2340	2344	type	type	NN	I-NP
O	2345	2346	2	2	CD	I-NP
O	2346	2347	)	)	)	O
O	2348	2350	to	to	TO	B-PP
O	2351	2357	normal	normal	JJ	B-NP
O	2358	2366	pregnant	pregnant	JJ	I-NP
O	2367	2371	rats	rat	NNS	I-NP
O	2372	2376	also	also	RB	B-ADVP
O	2377	2383	causes	cause	VBZ	B-VP
B-Developing_anatomical_structure	2384	2389	fetal	fetal	JJ	B-NP
O	2390	2396	growth	growth	NN	I-NP
O	2397	2408	retardation	retardation	NN	I-NP
O	2409	2412	and	and	CC	O
O	2413	2416	the	the	DT	B-NP
O	2417	2422	adult	adult	JJ	I-NP
O	2423	2432	offspring	offspring	NN	I-NP
O	2433	2436	are	be	VBP	B-VP
O	2437	2449	hypertensive	hypertensive	JJ	B-ADJP
O	2450	2453	and	and	CC	I-ADJP
O	2454	2467	hyperglycemic	hyperglycemic	JJ	I-ADJP
O	2467	2468	,	,	,	O
O	2469	2473	with	with	IN	B-PP
O	2474	2485	hyperactive	hyperactive	JJ	B-NP
B-Anatomical_system	2486	2498	hypothalamic	hypothalamic	JJ	I-NP
I-Anatomical_system	2498	2499	-	-	HYPH	I-NP
I-Anatomical_system	2499	2508	pituitary	pituitary	JJ	I-NP
I-Anatomical_system	2508	2509	-	-	HYPH	I-NP
I-Anatomical_system	2509	2516	adrenal	adrenal	JJ	I-NP
I-Anatomical_system	2517	2521	axis	axis	NN	I-NP
O	2522	2523	[	[	(	O
O	2523	2526	115	115	CD	B-NP
O	2526	2527	]	]	)	O
O	2527	2528	.	.	.	O

O	2529	2537	Maternal	Maternal	JJ	B-NP
O	2538	2552	undernutrition	undernutrition	NN	I-NP
O	2553	2566	significantly	significantly	RB	B-ADVP
O	2567	2576	increased	increase	VBD	B-VP
O	2577	2581	both	both	CC	O
B-Developing_anatomical_structure	2582	2587	fetal	fetal	JJ	B-NP
O	2588	2591	and	and	CC	I-NP
O	2592	2600	maternal	maternal	JJ	I-NP
O	2601	2615	corticosterone	corticosterone	NN	I-NP
O	2616	2630	concentrations	concentration	NNS	I-NP
O	2631	2633	in	in	IN	B-PP
O	2634	2638	rats	rat	NNS	B-NP
O	2639	2640	[	[	(	O
O	2640	2643	116	116	CD	B-NP
O	2643	2644	]	]	)	O
O	2644	2645	.	.	.	O

O	2646	2658	Subsequently	Subsequently	RB	B-ADVP
O	2658	2659	,	,	,	O
O	2660	2668	maternal	maternal	JJ	B-ADJP
O	2669	2672	and	and	CC	O
O	2672	2673	/	/	SYM	B-NP
O	2673	2675	or	or	CC	O
B-Developing_anatomical_structure	2676	2681	fetal	fetal	JJ	B-NP
O	2682	2694	overexposure	overexposure	NN	I-NP
O	2695	2697	to	to	TO	B-PP
O	2698	2713	glucocorticoids	glucocorticoid	NNS	B-NP
O	2714	2715	(	(	(	O
O	2715	2718	via	via	IN	B-PP
O	2719	2733	administration	administration	NN	B-NP
O	2734	2736	of	of	IN	B-PP
O	2737	2750	dexamethasone	dexamethasone	NN	B-NP
O	2750	2751	)	)	)	O
O	2752	2759	impairs	impair	VBZ	B-VP
O	2760	2764	both	both	CC	O
B-Developing_anatomical_structure	2765	2770	fetal	fetal	JJ	B-NP
O	2771	2774	and	and	CC	I-NP
O	2775	2784	postnatal	postnatal	JJ	I-NP
B-Cell	2785	2789	beta	beta	SYM	I-NP
I-Cell	2789	2790	-	-	HYPH	I-NP
I-Cell	2790	2794	cell	cell	NN	I-NP
O	2795	2804	formation	formation	NN	I-NP
O	2805	2807	in	in	IN	B-PP
O	2808	2815	rodents	rodent	NNS	B-NP
O	2816	2819	and	and	CC	O
O	2820	2828	nonhuman	nonhuman	JJ	B-NP
O	2829	2837	primates	primate	NNS	I-NP
O	2838	2839	[	[	(	O
O	2839	2841	94	94	CD	B-NP
O	2841	2842	,	,	,	I-NP
O	2843	2846	117	117	CD	I-NP
O	2846	2847	-	-	HYPH	I-NP
O	2847	2850	119	119	CD	I-NP
O	2850	2851	]	]	)	O
O	2851	2852	.	.	.	O

O	2853	2858	Seckl	Seckl	NNP	B-NP
O	2859	2861	et	et	FW	I-NP
O	2862	2864	al	al	FW	I-NP
O	2864	2865	.	.	.	O

O	2866	2867	[	[	(	O
O	2867	2870	115	115	CD	B-NP
O	2870	2871	]	]	)	O
O	2872	2876	have	have	VBP	B-VP
O	2877	2882	shown	show	VBN	I-VP
O	2883	2887	that	that	IN	B-SBAR
B-Developing_anatomical_structure	2888	2893	fetal	fetal	JJ	B-NP
O	2894	2908	corticosterone	corticosterone	NN	I-NP
O	2909	2923	concentrations	concentration	NNS	I-NP
O	2924	2927	are	be	VBP	B-VP
O	2928	2937	inversely	inversely	RB	I-VP
O	2938	2948	correlated	correlate	VBN	I-VP
O	2949	2953	with	with	IN	B-PP
B-Developing_anatomical_structure	2954	2959	fetal	fetal	JJ	B-NP
O	2960	2967	insulin	insulin	NN	I-NP
O	2968	2975	content	content	NN	I-NP
O	2976	2979	and	and	CC	O
O	2980	2989	postnatal	postnatal	JJ	B-NP
B-Cell	2990	2994	beta	beta	SYM	I-NP
I-Cell	2994	2995	-	-	HYPH	I-NP
I-Cell	2995	2999	cell	cell	NN	I-NP
O	3000	3009	formation	formation	NN	I-NP
O	3010	3012	in	in	IN	B-PP
O	3013	3017	rats	rat	NNS	B-NP
O	3017	3018	.	.	.	O

O	3019	3027	Evidence	Evidence	NN	B-NP
O	3028	3036	suggests	suggest	VBZ	B-VP
O	3037	3041	that	that	IN	B-SBAR
O	3042	3057	glucocorticoids	glucocorticoid	NNS	B-NP
O	3058	3061	can	can	MD	B-VP
O	3062	3067	exert	exert	VB	I-VP
O	3068	3069	a	a	DT	B-NP
O	3070	3076	direct	direct	JJ	I-NP
O	3077	3083	effect	effect	NN	I-NP
O	3084	3086	on	on	IN	B-PP
O	3087	3090	the	the	DT	B-NP
O	3091	3101	developing	develop	VBG	I-NP
B-Organ	3102	3107	fetal	fetal	JJ	I-NP
I-Organ	3108	3116	pancreas	pancreas	NN	I-NP
O	3117	3120	via	via	IN	B-PP
O	3121	3136	transcriptional	transcriptional	JJ	B-NP
O	3137	3147	modulation	modulation	NN	I-NP
O	3148	3150	of	of	IN	B-PP
O	3151	3164	transcription	transcription	NN	B-NP
O	3165	3172	factors	factor	NNS	I-NP
O	3173	3181	involved	involve	VBN	B-VP
O	3182	3184	in	in	IN	B-PP
B-Cell	3185	3189	beta	beta	SYM	B-NP
I-Cell	3189	3190	-	-	HYPH	O
I-Cell	3190	3194	cell	cell	NN	B-NP
O	3195	3204	formation	formation	NN	I-NP
O	3205	3208	and	and	CC	O
O	3209	3224	differentiation	differentiation	NN	B-NP
O	3225	3226	[	[	(	O
O	3226	3229	117	117	CD	B-NP
O	3229	3230	]	]	)	O
O	3230	3231	.	.	.	O

O	3232	3246	Glucocorticoid	Glucocorticoid	NN	B-NP
O	3247	3256	receptors	receptor	NNS	I-NP
O	3257	3260	are	be	VBP	B-VP
O	3261	3268	present	present	JJ	B-ADJP
O	3269	3271	in	in	IN	B-PP
O	3272	3275	the	the	DT	B-NP
B-Organ	3276	3284	pancreas	pancreas	NN	I-NP
O	3285	3291	during	during	IN	B-PP
B-Developing_anatomical_structure	3292	3301	embryonic	embryonic	JJ	B-NP
O	3302	3313	development	development	NN	I-NP
O	3314	3316	of	of	IN	B-PP
O	3317	3324	rodents	rodent	NNS	B-NP
O	3325	3328	and	and	CC	I-NP
O	3329	3335	humans	human	NNS	I-NP
O	3336	3337	[	[	(	O
O	3337	3340	117	117	CD	B-NP
O	3340	3341	]	]	)	O
O	3341	3342	,	,	,	O
O	3343	3346	and	and	CC	O
O	3347	3362	glucocorticoids	glucocorticoid	NNS	B-NP
O	3363	3366	can	can	MD	B-VP
O	3367	3371	bind	bind	VB	I-VP
O	3372	3374	to	to	TO	B-PP
O	3375	3378	the	the	DT	B-NP
O	3379	3383	Pdx1	Pdx1	NN	I-NP
O	3384	3392	promoter	promoter	NN	I-NP
O	3393	3396	and	and	CC	O
O	3397	3401	thus	thus	RB	B-VP
O	3402	3410	suppress	suppress	VBP	I-VP
B-Cell	3411	3416	fetal	fetal	JJ	B-NP
I-Cell	3417	3426	endocrine	endocrine	JJ	I-NP
I-Cell	3427	3431	cell	cell	NN	I-NP
O	3432	3447	differentiation	differentiation	NN	I-NP
O	3448	3449	[	[	(	O
O	3449	3452	117	117	CD	B-NP
O	3452	3453	]	]	)	O
O	3453	3454	.	.	.	O

O	3455	3469	Glucocorticoid	Glucocorticoid	NN	B-NP
O	3470	3479	treatment	treatment	NN	I-NP
O	3480	3483	has	have	VBZ	B-VP
O	3484	3488	been	be	VBN	I-VP
O	3489	3494	shown	show	VBN	I-VP
O	3495	3497	to	to	TO	I-VP
O	3498	3511	significantly	significantly	RB	I-VP
O	3512	3518	reduce	reduce	VB	I-VP
B-Developing_anatomical_structure	3519	3524	fetal	fetal	JJ	B-NP
O	3525	3535	expression	expression	NN	I-NP
O	3536	3538	of	of	IN	B-PP
O	3539	3542	key	key	JJ	B-NP
B-Anatomical_system	3543	3552	endocrine	endocrine	JJ	I-NP
O	3553	3566	transcription	transcription	NN	I-NP
O	3567	3574	factors	factor	NNS	I-NP
O	3575	3579	such	such	JJ	B-PP
O	3580	3582	as	as	IN	I-PP
O	3583	3587	Pdx1	Pdx1	NN	B-NP
O	3588	3591	and	and	CC	I-NP
O	3592	3596	Pax6	Pax6	NN	I-NP
O	3597	3600	but	but	CC	O
O	3601	3615	simultaneously	simultaneously	RB	B-VP
O	3616	3624	increase	increase	VBP	I-VP
O	3625	3635	expression	expression	NN	B-NP
O	3636	3638	of	of	IN	B-PP
O	3639	3652	transcription	transcription	NN	B-NP
O	3653	3660	factors	factor	NNS	I-NP
O	3661	3665	that	that	WDT	B-NP
O	3666	3674	regulate	regulate	VBP	B-VP
O	3675	3686	development	development	NN	B-NP
O	3687	3689	of	of	IN	B-PP
O	3690	3693	the	the	DT	B-NP
B-Organ	3694	3702	exocrine	exocrine	JJ	I-NP
I-Organ	3703	3711	pancreas	pancreas	NN	I-NP
O	3712	3713	[	[	(	O
O	3713	3716	119	119	CD	B-NP
O	3716	3717	]	]	)	O
O	3717	3718	.	.	.	O

O	3719	3721	It	It	PRP	B-NP
O	3722	3725	has	have	VBZ	B-VP
O	3726	3730	also	also	RB	I-VP
O	3731	3735	been	be	VBN	I-VP
O	3736	3748	demonstrated	demonstrate	VBN	I-VP
O	3749	3753	that	that	IN	B-SBAR
O	3754	3757	the	the	DT	B-NP
O	3758	3761	UPI	UPI	NNP	I-NP
O	3762	3764	or	or	CC	O
O	3765	3768	the	the	DT	B-NP
O	3769	3772	low	low	JJ	I-NP
O	3772	3773	-	-	HYPH	I-NP
O	3773	3780	protein	protein	NN	I-NP
O	3781	3785	IUPR	IUPR	NN	I-NP
O	3786	3795	offspring	offspring	NN	I-NP
O	3796	3806	experience	experience	NN	I-NP
O	3807	3816	increased	increase	VBD	B-VP
O	3817	3826	oxidative	oxidative	JJ	B-NP
O	3827	3833	stress	stress	NN	I-NP
O	3834	3837	and	and	CC	O
O	3838	3846	impaired	impaired	JJ	B-NP
B-Cellular_component	3847	3860	mitochondrial	mitochondrial	JJ	I-NP
O	3861	3869	function	function	NN	I-NP
O	3870	3871	[	[	(	O
O	3871	3873	96	96	CD	B-NP
O	3873	3874	,	,	,	I-NP
O	3875	3878	120	120	CD	I-NP
O	3878	3879	]	]	)	O
O	3879	3880	.	.	.	O

O	3881	3884	The	The	DT	B-NP
B-Cellular_component	3885	3898	mitochondrial	mitochondrial	JJ	I-NP
O	3899	3910	dysfunction	dysfunction	NN	I-NP
O	3911	3914	was	be	VBD	B-VP
O	3915	3918	not	not	RB	I-VP
O	3919	3926	limited	limit	VBN	I-VP
O	3927	3929	to	to	TO	B-PP
O	3930	3934	just	just	RB	B-NP
O	3935	3938	the	the	DT	I-NP
B-Cell	3939	3943	beta	beta	NN	I-NP
I-Cell	3944	3948	cell	cell	NN	I-NP
O	3948	3949	,	,	,	O
O	3950	3952	as	as	IN	B-SBAR
B-Cellular_component	3953	3965	mitochondria	mitochondrion	NNS	B-NP
O	3966	3970	from	from	IN	B-PP
O	3971	3975	both	both	CC	O
O	3976	3979	the	the	DT	B-NP
B-Organ	3980	3985	liver	liver	NN	I-NP
O	3986	3989	and	and	CC	I-NP
B-Organ	3990	3998	skeletal	skeletal	JJ	I-NP
I-Organ	3999	4005	muscle	muscle	NN	I-NP
O	4006	4013	exhibit	exhibit	VBP	B-VP
O	4014	4023	decreased	decrease	VBN	B-NP
O	4024	4033	oxidation	oxidation	NN	I-NP
O	4034	4036	of	of	IN	B-PP
O	4037	4045	pyruvate	pyruvate	NN	B-NP
O	4045	4046	,	,	,	O
O	4047	4059	subsequently	subsequently	RB	B-VP
O	4060	4067	leading	lead	VBG	I-VP
O	4068	4070	to	to	TO	B-PP
O	4071	4074	the	the	DT	B-NP
O	4075	4086	development	development	NN	I-NP
O	4087	4089	of	of	IN	B-PP
O	4090	4098	features	feature	NNS	B-NP
O	4099	4107	commonly	commonly	RB	B-VP
O	4108	4113	found	find	VBN	I-VP
O	4114	4116	in	in	IN	B-PP
O	4117	4120	T2D	T2D	NN	B-NP
O	4121	4122	[	[	(	O
O	4122	4125	100	100	CD	B-NP
O	4125	4126	,	,	,	I-NP
O	4127	4130	121	121	CD	I-NP
O	4130	4131	]	]	)	O
O	4131	4132	.	.	.	O

O	4133	4137	Also	Also	RB	B-NP
O	4138	4146	exposure	exposure	NN	I-NP
O	4147	4149	to	to	TO	B-PP
O	4150	4151	a	a	DT	B-NP
O	4152	4159	Western	Western	JJ	I-NP
O	4159	4160	-	-	HYPH	I-NP
O	4160	4165	style	style	NN	I-NP
O	4166	4170	diet	diet	NN	I-NP
O	4171	4177	before	before	IN	B-PP
O	4178	4181	and	and	CC	I-PP
O	4182	4188	during	during	IN	I-PP
O	4189	4198	pregnancy	pregnancy	NN	B-NP
O	4199	4200	(	(	(	O
O	4200	4202	an	an	DT	B-NP
O	4203	4207	IUEO	IUEO	NN	I-NP
O	4208	4213	model	model	NN	I-NP
O	4213	4214	)	)	)	O
O	4215	4221	alters	alter	VBZ	B-VP
O	4222	4225	the	the	DT	B-NP
O	4226	4231	redox	redox	NN	I-NP
O	4232	4237	state	state	NN	I-NP
O	4238	4240	as	as	RB	B-ADVP
O	4241	4246	early	early	RB	I-ADVP
O	4247	4249	as	as	IN	B-PP
O	4250	4265	preimplantation	preimplantation	NN	B-NP
O	4266	4277	development	development	NN	I-NP
O	4277	4278	,	,	,	O
O	4279	4286	leading	lead	VBG	B-VP
O	4287	4289	to	to	TO	B-PP
O	4290	4294	mild	mild	JJ	B-NP
O	4295	4304	oxidative	oxidative	JJ	I-NP
O	4305	4311	stress	stress	NN	I-NP
O	4312	4322	associated	associate	VBN	B-VP
O	4323	4327	with	with	IN	B-PP
O	4328	4340	inflammation	inflammation	NN	B-NP
O	4340	4341	.	.	.	O

O	4342	4345	The	The	DT	B-NP
O	4346	4353	finding	finding	NN	I-NP
O	4354	4358	that	that	IN	B-SBAR
O	4359	4373	administration	administration	NN	B-NP
O	4374	4376	of	of	IN	B-PP
O	4377	4389	antioxidants	antioxidant	NNS	B-NP
O	4390	4392	to	to	TO	B-PP
O	4393	4396	the	the	DT	B-NP
O	4397	4400	dam	dam	NN	I-NP
O	4401	4409	reverses	reverse	VBZ	B-VP
O	4410	4419	oxidative	oxidative	JJ	B-NP
O	4420	4426	stress	stress	NN	I-NP
O	4427	4430	and	and	CC	O
O	4431	4441	completely	completely	RB	B-VP
O	4442	4450	prevents	prevent	VBZ	I-VP
O	4451	4454	the	the	DT	B-NP
O	4455	4466	development	development	NN	I-NP
O	4467	4469	of	of	IN	B-PP
O	4470	4477	glucose	glucose	NN	B-NP
O	4478	4489	intolerance	intolerance	NN	I-NP
O	4490	4493	and	and	CC	O
O	4494	4503	increased	increase	VBN	B-NP
O	4504	4513	adiposity	adiposity	NN	I-NP
O	4514	4516	in	in	IN	B-PP
O	4517	4520	the	the	DT	B-NP
O	4521	4526	adult	adult	JJ	I-NP
O	4527	4536	offspring	offspring	NN	I-NP
O	4537	4545	suggests	suggest	VBZ	B-VP
O	4546	4550	that	that	IN	B-SBAR
O	4551	4560	oxidative	oxidative	JJ	B-NP
O	4561	4567	stress	stress	NN	I-NP
O	4568	4573	plays	play	VBZ	B-VP
O	4574	4576	an	an	DT	B-NP
O	4577	4586	important	important	JJ	I-NP
O	4587	4591	role	role	NN	I-NP
O	4592	4594	in	in	IN	B-PP
O	4595	4598	the	the	DT	B-NP
O	4599	4610	development	development	NN	I-NP
O	4611	4613	of	of	IN	B-PP
O	4614	4623	adiposity	adiposity	NN	B-NP
O	4624	4626	in	in	IN	B-PP
O	4627	4631	this	this	DT	B-NP
O	4632	4636	case	case	NN	I-NP
O	4637	4638	[	[	(	O
O	4638	4641	122	122	CD	B-NP
O	4641	4642	]	]	)	O
O	4642	4643	.	.	.	O

O	4644	4648	Some	Some	DT	B-NP
O	4649	4656	studies	study	NNS	I-NP
O	4657	4659	in	in	IN	B-PP
O	4660	4663	the	the	DT	B-NP
O	4664	4667	low	low	JJ	I-NP
O	4667	4668	-	-	HYPH	I-NP
O	4668	4675	protein	protein	NN	I-NP
O	4676	4680	IUPR	IUPR	NN	I-NP
O	4681	4686	model	model	NN	I-NP
O	4687	4691	have	have	VBP	B-VP
O	4692	4704	demonstrated	demonstrate	VBN	I-VP
O	4705	4709	that	that	IN	B-SBAR
O	4710	4719	oxidative	oxidative	JJ	B-NP
O	4720	4726	stress	stress	NN	I-NP
O	4727	4729	is	be	VBZ	B-VP
O	4730	4733	not	not	RB	I-VP
O	4734	4741	limited	limit	VBN	I-VP
O	4742	4744	to	to	TO	B-PP
O	4745	4749	just	just	RB	B-NP
B-Cellular_component	4750	4763	mitochondrial	mitochondrial	JJ	I-NP
O	4764	4767	DNA	DNA	NN	I-NP
O	4768	4774	damage	damage	NN	I-NP
O	4774	4775	,	,	,	O
O	4776	4779	but	but	CC	B-CONJP
O	4780	4784	also	also	RB	I-CONJP
O	4785	4787	to	to	TO	B-PP
O	4788	4795	genomic	genomic	JJ	B-NP
O	4796	4799	DNA	DNA	NN	I-NP
O	4799	4800	,	,	,	O
O	4801	4810	impacting	impact	VBG	B-VP
B-Cell	4811	4815	cell	cell	NN	B-NP
O	4815	4816	-	-	HYPH	B-NP
O	4816	4821	cycle	cycle	NN	I-NP
O	4822	4832	regulation	regulation	NN	I-NP
O	4833	4836	and	and	CC	O
O	4837	4841	gene	gene	NN	B-NP
O	4842	4852	expression	expression	NN	I-NP
O	4853	4854	[	[	(	O
O	4854	4857	123	123	CD	B-NP
O	4857	4858	]	]	)	O
O	4858	4859	.	.	.	O

O	4860	4865	While	While	IN	B-SBAR
O	4866	4869	DNA	DNA	NN	B-NP
O	4870	4872	is	be	VBZ	B-VP
O	4873	4878	being	be	VBG	I-VP
O	4879	4887	targeted	target	VBN	I-VP
O	4888	4898	throughout	throughout	IN	B-ADVP
O	4899	4901	by	by	IN	B-PP
O	4902	4905	ROS	ROS	NN	B-NP
O	4905	4906	,	,	,	O
O	4907	4912	there	there	EX	B-NP
O	4913	4916	are	be	VBP	B-VP
O	4917	4927	particular	particular	JJ	B-NP
O	4928	4935	regions	region	NNS	I-NP
O	4936	4940	that	that	WDT	B-NP
O	4941	4944	are	be	VBP	B-VP
O	4945	4950	known	know	VBN	I-VP
O	4951	4953	to	to	TO	I-VP
O	4954	4956	be	be	VB	I-VP
O	4957	4961	more	more	RBR	B-ADJP
O	4962	4971	sensitive	sensitive	JJ	I-ADJP
O	4972	4974	to	to	TO	B-PP
O	4975	4978	ROS	ROS	NN	B-NP
O	4978	4979	-	-	HYPH	B-NP
O	4979	4987	mediated	mediate	VBN	I-NP
O	4988	4994	damage	damage	NN	I-NP
O	4994	4995	,	,	,	O
O	4996	4999	for	for	IN	B-PP
O	5000	5007	example	example	NN	B-NP
O	5007	5008	,	,	,	O
B-Cellular_component	5009	5018	telomeres	telomere	VBZ	B-VP
O	5018	5019	.	.	.	O

B-Cellular_component	5020	5029	Telomeres	Telomere	NNPS	B-NP
O	5030	5038	comprise	comprise	VBP	B-VP
O	5039	5041	GC	GC	NN	B-NP
O	5041	5042	-	-	HYPH	B-NP
O	5042	5046	rich	rich	JJ	I-NP
O	5047	5054	repeats	repeat	NNS	I-NP
O	5055	5058	and	and	CC	O
O	5059	5062	are	be	VBP	B-VP
O	5063	5068	found	find	VBN	I-VP
O	5069	5071	at	at	IN	B-PP
O	5072	5075	the	the	DT	B-NP
O	5076	5080	ends	end	NNS	I-NP
O	5081	5083	of	of	IN	B-PP
O	5084	5088	each	each	DT	B-NP
B-Cellular_component	5089	5099	chromosome	chromosome	NN	I-NP
O	5099	5100	.	.	.	O

O	5101	5105	They	They	PRP	B-NP
O	5106	5109	are	be	VBP	B-VP
O	5110	5115	known	know	VBN	I-VP
O	5116	5118	to	to	TO	I-VP
O	5119	5126	shorten	shorten	VB	I-VP
O	5127	5131	with	with	IN	B-PP
O	5132	5136	each	each	DT	B-NP
B-Cell	5137	5145	cellular	cellular	JJ	I-NP
O	5146	5154	division	division	NN	I-NP
O	5155	5158	and	and	CC	O
O	5158	5159	,	,	,	O
O	5160	5165	hence	hence	RB	B-ADVP
O	5165	5166	,	,	,	O
O	5167	5170	can	can	MD	B-VP
O	5171	5174	act	act	VB	I-VP
O	5175	5177	as	as	IN	B-PP
O	5178	5179	a	a	DT	B-NP
O	5180	5187	mitotic	mitotic	JJ	I-NP
O	5188	5193	clock	clock	NN	I-NP
O	5193	5194	,	,	,	O
O	5195	5206	registering	register	VBG	B-VP
O	5207	5210	the	the	DT	B-NP
O	5211	5217	number	number	NN	I-NP
O	5218	5220	of	of	IN	B-PP
O	5221	5232	replicative	replicative	JJ	B-NP
O	5233	5242	divisions	division	NNS	I-NP
O	5243	5245	to	to	TO	B-VP
O	5246	5250	have	have	VB	I-VP
O	5251	5256	taken	take	VBN	I-VP
O	5257	5262	place	place	NN	B-NP
O	5263	5269	within	within	IN	B-PP
O	5270	5273	the	the	DT	B-NP
B-Cell	5274	5278	cell	cell	NN	I-NP
O	5278	5279	.	.	.	O

O	5280	5294	Investigations	Investigation	NNS	B-NP
O	5295	5300	using	use	VBG	B-VP
O	5301	5303	an	an	DT	B-NP
O	5304	5308	IUPR	IUPR	NN	I-NP
O	5309	5314	model	model	NN	I-NP
O	5315	5319	have	have	VBP	B-VP
O	5320	5326	indeed	indeed	RB	I-VP
O	5327	5335	reported	report	VBN	I-VP
O	5336	5337	a	a	DT	B-NP
O	5338	5346	decrease	decrease	NN	I-NP
O	5347	5349	in	in	IN	B-PP
O	5350	5359	longevity	longevity	NN	B-NP
O	5360	5362	in	in	IN	B-PP
O	5363	5366	the	the	DT	B-NP
O	5367	5376	offspring	offspring	NN	I-NP
O	5377	5378	[	[	(	O
O	5378	5381	123	123	CD	B-NP
O	5381	5382	,	,	,	I-NP
O	5383	5386	124	124	CD	I-NP
O	5386	5387	]	]	)	O
O	5388	5399	accompanied	accompany	VBN	B-VP
O	5400	5402	by	by	IN	B-PP
O	5403	5412	reduction	reduction	NN	B-NP
O	5413	5415	in	in	IN	B-PP
B-Cellular_component	5416	5429	mitochondrial	mitochondrial	JJ	B-NP
O	5430	5441	antioxidant	antioxidant	JJ	I-NP
O	5442	5450	defences	defence	NNS	I-NP
O	5451	5452	[	[	(	O
O	5452	5454	96	96	CD	B-NP
O	5454	5455	,	,	,	I-NP
O	5456	5459	125	125	CD	I-NP
O	5459	5460	]	]	)	O
O	5461	5464	and	and	CC	O
B-Cellular_component	5465	5473	telomere	telomere	VBP	B-VP
O	5474	5480	length	length	NN	B-NP
O	5481	5483	in	in	IN	B-PP
B-Multi-tissue_structure	5484	5490	islets	islet	NNS	B-NP
O	5491	5492	[	[	(	O
O	5492	5495	125	125	CD	B-NP
O	5495	5496	]	]	)	O
O	5496	5497	.	.	.	O

B-Multi-tissue_structure	5498	5508	Pancreatic	Pancreatic	JJ	B-NP
I-Multi-tissue_structure	5509	5514	islet	islet	NN	I-NP
O	5515	5526	development	development	NN	I-NP
O	5527	5530	has	have	VBZ	B-VP
O	5531	5535	been	be	VBN	I-VP
O	5536	5541	shown	show	VBN	I-VP
O	5542	5544	to	to	TO	I-VP
O	5545	5547	be	be	VB	I-VP
O	5548	5558	influenced	influence	VBN	I-VP
O	5559	5561	by	by	IN	B-PP
O	5562	5563	a	a	DT	B-NP
O	5564	5570	number	number	NN	I-NP
O	5571	5573	of	of	IN	B-PP
O	5574	5580	growth	growth	NN	B-NP
O	5581	5588	factors	factor	NNS	I-NP
O	5589	5598	including	include	VBG	B-PP
O	5599	5602	the	the	DT	B-NP
O	5603	5610	insulin	insulin	NN	I-NP
O	5610	5611	-	-	HYPH	B-NP
O	5611	5615	like	like	JJ	I-NP
O	5616	5622	growth	growth	NN	I-NP
O	5623	5630	factors	factor	NNS	I-NP
O	5630	5631	,	,	,	O
O	5632	5635	IGF	IGF	NN	B-NP
O	5635	5636	-	-	HYPH	I-NP
O	5636	5637	I	I	NN	I-NP
O	5638	5641	and	and	CC	I-NP
O	5642	5645	IGF	IGF	NN	I-NP
O	5645	5646	-	-	HYPH	O
O	5646	5648	II	II	CD	B-NP
O	5649	5654	whose	whose	WP$	B-NP
O	5655	5665	expression	expression	NN	I-NP
O	5666	5668	in	in	IN	B-PP
O	5669	5674	utero	utero	NN	B-NP
O	5675	5677	is	be	VBZ	B-VP
O	5678	5687	regulated	regulate	VBN	I-VP
O	5688	5690	by	by	IN	B-PP
O	5691	5699	nutrient	nutrient	NN	B-NP
O	5700	5703	and	and	CC	I-NP
O	5704	5711	hormone	hormone	NN	I-NP
O	5712	5726	concentrations	concentration	NNS	I-NP
O	5726	5727	.	.	.	O

O	5728	5732	IUPR	IUPR	NN	B-NP
O	5733	5741	modifies	modify	VBZ	B-VP
O	5742	5752	expression	expression	NN	B-NP
O	5753	5755	of	of	IN	B-PP
O	5756	5760	both	both	DT	B-NP
O	5761	5764	IGF	IGF	NN	I-NP
O	5765	5770	genes	gene	NNS	I-NP
O	5771	5773	in	in	IN	B-PP
O	5774	5775	a	a	DT	B-NP
O	5776	5783	variety	variety	NN	I-NP
O	5784	5786	of	of	IN	B-PP
B-Tissue	5787	5792	fetal	fetal	JJ	B-NP
I-Tissue	5793	5800	tissues	tissue	NNS	I-NP
O	5800	5801	.	.	.	O

O	5802	5804	In	In	IN	B-PP
O	5805	5807	an	an	DT	B-NP
O	5808	5812	IUPR	IUPR	NN	I-NP
O	5813	5816	rat	rat	NN	I-NP
O	5817	5822	model	model	NN	I-NP
O	5823	5827	with	with	IN	B-PP
O	5828	5829	a	a	DT	B-NP
O	5830	5839	decreased	decrease	VBN	I-NP
B-Cell	5840	5844	beta	beta	SYM	I-NP
I-Cell	5844	5845	-	-	HYPH	I-NP
I-Cell	5845	5849	cell	cell	NN	I-NP
O	5850	5854	mass	mass	NN	I-NP
O	5855	5858	and	and	CC	O
B-Cell	5859	5863	beta	beta	SYM	O
I-Cell	5863	5864	-	-	HYPH	O
I-Cell	5864	5868	cell	cell	NN	B-NP
O	5869	5880	replication	replication	NN	I-NP
O	5881	5884	and	and	CC	O
O	5885	5887	an	an	DT	B-NP
O	5888	5897	increased	increase	VBN	I-NP
O	5898	5902	rate	rate	NN	I-NP
O	5903	5905	of	of	IN	B-PP
B-Cell	5906	5910	beta	beta	SYM	B-NP
I-Cell	5910	5911	-	-	HYPH	B-NP
I-Cell	5911	5915	cell	cell	NN	I-NP
O	5916	5925	apoptosis	apoptosis	NN	I-NP
O	5925	5926	,	,	,	O
O	5927	5931	gene	gene	NN	B-NP
O	5932	5942	expression	expression	NN	I-NP
O	5943	5946	for	for	IN	B-PP
O	5947	5950	IGF	IGF	NN	B-NP
O	5950	5951	-	-	HYPH	O
O	5951	5953	II	II	CD	B-NP
O	5954	5957	but	but	CC	I-NP
O	5958	5961	not	not	RB	I-NP
O	5962	5965	IGF	IGF	NN	B-NP
O	5965	5966	-	-	HYPH	O
O	5966	5967	I	I	PRP	B-NP
O	5968	5971	was	be	VBD	B-VP
O	5972	5977	found	find	VBN	I-VP
O	5978	5985	reduced	reduce	VBN	I-VP
O	5986	5988	in	in	IN	B-PP
O	5989	5992	the	the	DT	B-NP
B-Organ	5993	5998	fetal	fetal	JJ	I-NP
I-Organ	5999	6007	pancreas	pancreas	NN	I-NP
O	6008	6009	[	[	(	O
O	6009	6012	126	126	CD	B-NP
O	6012	6013	]	]	)	O
O	6013	6014	.	.	.	O

O	6015	6017	In	In	IN	B-PP
O	6018	6019	a	a	DT	B-NP
O	6020	6029	different	different	JJ	I-NP
O	6030	6034	IUPR	IUPR	NN	I-NP
O	6035	6040	model	model	NN	I-NP
O	6041	6045	with	with	IN	B-PP
O	6046	6050	more	more	RBR	B-NP
O	6051	6057	severe	severe	JJ	I-NP
O	6058	6064	global	global	JJ	I-NP
O	6065	6069	food	food	NN	I-NP
O	6070	6081	restriction	restriction	NN	I-NP
O	6082	6087	which	which	WDT	B-NP
O	6088	6095	induced	induce	VBD	B-VP
O	6096	6112	hyperinsulinemia	hyperinsulinemia	NN	B-NP
O	6113	6116	and	and	CC	O
O	6117	6119	an	an	DT	B-NP
O	6120	6128	increase	increase	NN	I-NP
O	6129	6131	in	in	IN	B-PP
B-Cell	6132	6136	beta	beta	SYM	B-NP
I-Cell	6136	6137	-	-	HYPH	B-NP
I-Cell	6137	6141	cell	cell	NN	I-NP
O	6142	6146	mass	mass	NN	I-NP
O	6147	6149	in	in	IN	B-PP
O	6150	6155	their	their	PRP$	B-NP
B-Developing_anatomical_structure	6156	6163	fetuses	fetus	NNS	I-NP
O	6164	6165	[	[	(	O
O	6165	6167	90	90	CD	B-NP
O	6167	6168	]	]	)	O
O	6168	6169	,	,	,	O
O	6170	6173	the	the	DT	B-NP
B-Developing_anatomical_structure	6174	6179	fetal	fetal	JJ	I-NP
O	6180	6189	phenotype	phenotype	NN	I-NP
O	6190	6193	was	be	VBD	B-VP
O	6194	6206	unexpectedly	unexpectedly	RB	I-VP
O	6207	6217	associated	associate	VBN	I-VP
O	6218	6222	with	with	IN	B-PP
O	6223	6225	an	an	DT	B-NP
O	6226	6234	increase	increase	NN	I-NP
O	6235	6237	in	in	IN	B-PP
B-Organ	6238	6248	pancreatic	pancreatic	JJ	B-NP
O	6249	6252	IGF	IGF	NN	I-NP
O	6252	6253	-	-	HYPH	B-NP
O	6253	6254	I	I	NN	I-NP
O	6255	6265	expression	expression	NN	I-NP
O	6265	6266	,	,	,	O
B-Multi-tissue_structure	6267	6272	islet	islet	NN	B-NP
O	6273	6276	IGF	IGF	NN	I-NP
O	6276	6277	-	-	HYPH	B-NP
O	6277	6279	1R	1R	NN	I-NP
O	6280	6281	[	[	(	O
O	6281	6283	91	91	CD	B-NP
O	6283	6284	]	]	)	O
O	6284	6285	,	,	,	O
O	6286	6289	and	and	CC	O
O	6290	6293	IRS	IRS	NNP	B-NP
O	6293	6294	-	-	HYPH	B-NP
O	6294	6295	2	2	CD	I-NP
O	6296	6297	[	[	(	O
O	6297	6299	92	92	CD	B-NP
O	6299	6300	]	]	)	O
O	6300	6301	.	.	.	O

O	6302	6304	In	In	IN	B-PP
O	6305	6308	the	the	DT	B-NP
B-Developing_anatomical_structure	6309	6314	fetal	fetal	JJ	I-NP
O	6315	6317	GK	GK	NN	I-NP
O	6317	6318	/	/	SYM	B-NP
O	6318	6321	Par	Par	NN	I-NP
O	6322	6325	rat	rat	NN	I-NP
O	6326	6333	exposed	expose	VBN	B-VP
O	6334	6336	to	to	TO	B-PP
O	6337	6341	mild	mild	JJ	B-NP
O	6342	6355	hyperglycemia	hyperglycemia	NN	I-NP
O	6356	6362	during	during	IN	B-PP
O	6363	6372	gestation	gestation	NN	B-NP
O	6373	6374	(	(	(	O
O	6374	6375	a	a	DT	B-NP
O	6376	6381	model	model	NN	I-NP
O	6382	6384	of	of	IN	B-PP
O	6385	6389	IUED	IUED	NN	B-NP
O	6389	6390	)	)	)	O
O	6390	6391	,	,	,	O
O	6392	6396	data	datum	NNS	B-NP
O	6397	6401	from	from	IN	B-PP
O	6402	6405	our	our	PRP$	B-NP
O	6406	6411	group	group	NN	I-NP
O	6412	6419	suggest	suggest	VBP	B-VP
O	6420	6424	that	that	IN	B-SBAR
O	6425	6428	the	the	DT	B-NP
B-Cell	6429	6433	beta	beta	SYM	I-NP
I-Cell	6433	6434	-	-	HYPH	I-NP
I-Cell	6434	6438	cell	cell	NN	I-NP
O	6439	6446	deficit	deficit	NN	I-NP
O	6447	6448	(	(	(	O
O	6448	6455	reduced	reduce	VBN	B-VP
O	6456	6458	by	by	IN	B-PP
O	6459	6463	more	more	JJR	B-NP
O	6464	6468	than	than	IN	I-NP
O	6469	6471	50	50	CD	I-NP
O	6471	6472	%	%	NN	I-NP
O	6472	6473	)	)	)	O
O	6474	6480	starts	start	VBZ	B-VP
O	6481	6483	as	as	RB	B-ADVP
O	6484	6489	early	early	RB	I-ADVP
O	6490	6492	as	as	IN	B-PP
B-Developing_anatomical_structure	6493	6498	fetal	fetal	JJ	B-NP
O	6499	6502	age	age	NN	I-NP
O	6503	6506	E16	E16	NN	I-NP
O	6507	6510	and	and	CC	O
O	6511	6519	reflects	reflect	VBZ	B-VP
O	6520	6529	decreased	decrease	VBN	I-VP
B-Cell	6530	6534	beta	beta	SYM	B-NP
I-Cell	6534	6535	-	-	HYPH	B-NP
I-Cell	6535	6539	cell	cell	NN	I-NP
O	6540	6553	proliferation	proliferation	NN	I-NP
O	6553	6554	,	,	,	O
O	6555	6556	a	a	DT	B-NP
O	6557	6567	limitation	limitation	NN	I-NP
O	6568	6570	of	of	IN	B-PP
B-Cell	6571	6575	beta	beta	SYM	B-NP
I-Cell	6575	6576	-	-	HYPH	I-NP
I-Cell	6576	6580	cell	cell	NN	I-NP
O	6581	6591	neogenesis	neogenesis	NN	I-NP
O	6592	6596	from	from	IN	B-PP
B-Cell	6597	6607	precursors	precursor	NNS	B-NP
O	6607	6608	,	,	,	O
O	6609	6612	and	and	CC	O
O	6613	6622	increased	increase	VBN	B-NP
O	6623	6632	apoptosis	apoptosis	NN	I-NP
O	6633	6635	of	of	IN	B-PP
O	6636	6640	both	both	DT	B-NP
B-Cell	6641	6645	beta	beta	NN	I-NP
I-Cell	6646	6651	cells	cell	NNS	I-NP
O	6652	6655	and	and	CC	O
O	6656	6661	their	their	PRP$	B-NP
B-Cell	6662	6672	precursors	precursor	NNS	I-NP
O	6673	6674	[	[	(	O
O	6674	6676	86	86	CD	B-NP
O	6676	6677	]	]	)	O
O	6677	6678	.	.	.	O

O	6679	6686	Notably	Notably	RB	B-ADVP
O	6686	6687	,	,	,	O
O	6688	6692	Pdx1	Pdx1	NN	B-NP
O	6693	6696	and	and	CC	O
O	6697	6708	Neurogenin3	Neurogenin3	NN	B-NP
O	6709	6719	expression	expression	NN	I-NP
O	6720	6724	were	be	VBD	B-VP
O	6725	6734	decreased	decrease	VBN	I-VP
O	6735	6737	on	on	IN	B-PP
O	6738	6741	E18	E18	NN	B-NP
O	6742	6745	but	but	CC	O
O	6746	6754	normally	normally	RB	B-VP
O	6755	6764	expressed	express	VBN	I-VP
O	6765	6767	on	on	IN	B-PP
O	6768	6771	E13	E13	NN	B-NP
O	6772	6773	[	[	(	O
O	6773	6775	86	86	CD	B-NP
O	6775	6776	]	]	)	O
O	6776	6777	.	.	.	O

O	6778	6787	Defective	Defective	JJ	B-NP
O	6788	6798	signalling	signalling	NN	I-NP
O	6799	6806	through	through	IN	B-PP
O	6807	6810	the	the	DT	B-NP
O	6811	6815	Igf2	Igf2	NN	I-NP
O	6815	6816	/	/	SYM	B-NP
O	6816	6820	Igf1	Igf1	NN	I-NP
O	6820	6821	-	-	HYPH	B-NP
O	6821	6822	R	R	NN	I-NP
O	6823	6830	pathway	pathway	NN	I-NP
O	6831	6834	may	may	MD	B-VP
O	6835	6844	represent	represent	VB	I-VP
O	6845	6848	the	the	DT	B-NP
O	6849	6856	primary	primary	JJ	I-NP
O	6857	6869	instrumental	instrumental	JJ	I-NP
O	6870	6877	anomaly	anomaly	RB	B-ADVP
O	6878	6883	since	since	IN	B-PP
O	6884	6888	Igf2	Igf2	NN	B-NP
O	6889	6892	and	and	CC	I-NP
O	6893	6897	Igf1	Igf1	NN	I-NP
O	6897	6898	-	-	HYPH	B-NP
O	6898	6899	R	R	NN	I-NP
O	6900	6907	protein	protein	NN	I-NP
O	6908	6919	expressions	expression	NNS	I-NP
O	6920	6923	are	be	VBP	B-VP
O	6924	6931	already	already	RB	I-VP
O	6932	6941	decreased	decrease	VBN	I-VP
O	6942	6948	within	within	IN	B-PP
O	6949	6952	the	the	DT	B-NP
O	6953	6955	GK	GK	NN	I-NP
O	6955	6956	/	/	SYM	B-NP
O	6956	6959	Par	Par	NN	I-NP
B-Organ	6960	6970	pancreatic	pancreatic	JJ	I-NP
I-Organ	6971	6979	rudiment	rudiment	NN	I-NP
O	6980	6982	at	at	IN	B-PP
O	6983	6986	E13	E13	NN	B-NP
O	6986	6987	,	,	,	O
O	6988	6990	at	at	IN	B-PP
O	6991	6992	a	a	DT	B-NP
O	6993	6997	time	time	NN	I-NP
O	6998	7002	when	when	WRB	B-ADVP
B-Cell	7003	7007	beta	beta	SYM	O
I-Cell	7007	7008	-	-	HYPH	O
I-Cell	7008	7012	cell	cell	NN	B-NP
O	7013	7017	mass	mass	NN	I-NP
O	7018	7019	(	(	(	O
O	7019	7024	first	first	JJ	B-NP
O	7025	7029	wave	wave	NN	I-NP
O	7030	7032	of	of	IN	B-PP
B-Cell	7033	7037	beta	beta	SYM	B-NP
I-Cell	7037	7038	-	-	HYPH	I-NP
I-Cell	7038	7042	cell	cell	NN	I-NP
O	7043	7052	expansion	expansion	NN	I-NP
O	7052	7053	)	)	)	O
O	7054	7056	is	be	VBZ	B-VP
O	7057	7059	in	in	IN	B-PP
O	7060	7064	fact	fact	NN	B-NP
O	7065	7071	normal	normal	JJ	B-ADJP
O	7072	7073	[	[	(	O
O	7073	7075	31	31	CD	B-NP
O	7075	7076	]	]	)	O
O	7076	7077	.	.	.	O

O	7078	7081	Low	Low	JJ	B-NP
O	7082	7088	levels	level	NNS	I-NP
O	7089	7091	of	of	IN	B-PP
B-Organ	7092	7102	pancreatic	pancreatic	JJ	B-NP
O	7103	7107	Igf2	Igf2	NN	I-NP
O	7108	7118	associated	associate	VBN	B-VP
O	7119	7123	with	with	IN	B-PP
B-Cell	7124	7128	beta	beta	SYM	B-NP
I-Cell	7128	7129	-	-	HYPH	I-NP
I-Cell	7129	7133	cell	cell	NN	I-NP
O	7134	7138	mass	mass	NN	I-NP
O	7139	7149	deficiency	deficiency	NN	I-NP
O	7150	7153	are	be	VBP	B-VP
O	7154	7164	maintained	maintain	VBN	I-VP
O	7165	7175	thereafter	thereafter	RB	B-ADVP
O	7176	7182	within	within	IN	B-PP
O	7183	7186	the	the	DT	B-NP
B-Organ	7187	7192	fetal	fetal	JJ	I-NP
I-Organ	7193	7201	pancreas	pancreas	NN	I-NP
O	7202	7203	[	[	(	O
O	7203	7205	87	87	CD	B-NP
O	7205	7206	]	]	)	O
O	7206	7207	.	.	.	O

O	7208	7221	Crossbreeding	Crossbreed	VBG	B-VP
O	7222	7231	protocols	protocol	NNS	B-NP
O	7232	7239	between	between	IN	B-PP
O	7240	7251	nondiabetic	nondiabetic	JJ	B-NP
O	7252	7253	W	W	NN	I-NP
O	7254	7257	and	and	CC	O
O	7258	7266	diabetic	diabetic	JJ	B-NP
O	7267	7269	GK	GK	NN	I-NP
O	7270	7274	rats	rat	NNS	I-NP
O	7275	7281	showed	show	VBD	B-VP
O	7282	7286	that	that	IN	B-SBAR
O	7286	7287	,	,	,	O
O	7288	7290	in	in	IN	B-PP
O	7291	7295	late	late	JJ	B-NP
O	7296	7305	gestation	gestation	NN	I-NP
O	7306	7307	(	(	(	O
O	7307	7310	E18	E18	NN	B-NP
O	7310	7311	)	)	)	O
O	7311	7312	,	,	,	O
B-Organ	7313	7323	pancreatic	pancreatic	JJ	B-NP
O	7324	7328	Igf2	Igf2	NN	I-NP
O	7329	7336	protein	protein	NN	I-NP
O	7337	7347	expression	expression	NN	I-NP
O	7348	7351	was	be	VBD	B-VP
O	7352	7354	as	as	RB	B-ADJP
O	7355	7358	low	low	JJ	I-ADJP
O	7359	7361	in	in	IN	B-PP
O	7362	7370	GKmother	GKmother	NN	B-NP
O	7370	7371	/	/	SYM	B-NP
O	7371	7379	GKfather	GKfather	NN	I-NP
O	7380	7383	and	and	CC	I-NP
O	7384	7391	Wmother	Wmother	NN	I-NP
O	7391	7392	/	/	SYM	B-NP
O	7392	7400	GKfather	GKfather	NN	B-NP
O	7401	7408	crosses	crosse	NNS	I-NP
O	7409	7411	as	as	IN	B-PP
O	7412	7414	in	in	IN	B-PP
O	7415	7423	GKmother	GKmother	NN	B-NP
O	7423	7424	/	/	SYM	O
O	7424	7432	GKfather	GKfather	NN	B-NP
O	7433	7440	crosses	crosse	NNS	I-NP
O	7441	7442	[	[	(	O
O	7442	7444	87	87	CD	B-NP
O	7444	7445	]	]	)	O
O	7445	7446	.	.	.	O

O	7447	7452	These	These	DT	B-NP
O	7453	7461	findings	finding	NNS	I-NP
O	7462	7468	rather	rather	RB	B-ADVP
O	7469	7476	support	support	VBP	B-VP
O	7477	7480	the	the	DT	B-NP
O	7481	7491	hypothesis	hypothesis	NN	I-NP
O	7492	7496	that	that	IN	B-SBAR
O	7497	7500	the	the	DT	B-NP
B-Organ	7501	7511	pancreatic	pancreatic	JJ	I-NP
O	7512	7516	Igf2	Igf2	NN	I-NP
O	7517	7524	anomaly	anomaly	RB	B-ADVP
O	7525	7527	in	in	IN	B-PP
O	7528	7531	the	the	DT	B-NP
O	7532	7534	GK	GK	NN	I-NP
O	7535	7543	diabetic	diabetic	JJ	I-NP
O	7544	7549	model	model	NN	I-NP
O	7550	7552	is	be	VBZ	B-VP
O	7553	7559	linked	link	VBN	I-VP
O	7560	7562	to	to	TO	B-PP
O	7563	7564	a	a	DT	B-NP
O	7565	7572	genetic	genetic	JJ	I-NP
O	7573	7584	determinism	determinism	NN	I-NP
O	7584	7585	.	.	.	O

O	7586	7590	This	This	DT	B-NP
O	7591	7595	view	view	NN	I-NP
O	7596	7598	is	be	VBZ	B-VP
O	7599	7603	also	also	RB	B-ADVP
O	7604	7614	consistent	consistent	JJ	B-ADJP
O	7615	7619	with	with	IN	B-PP
O	7620	7623	the	the	DT	B-NP
O	7624	7631	results	result	NNS	I-NP
O	7632	7634	of	of	IN	B-PP
O	7635	7642	genetic	genetic	JJ	B-NP
O	7643	7651	analyses	analysis	NNS	I-NP
O	7652	7656	that	that	WDT	B-NP
O	7657	7663	linked	link	VBD	B-VP
O	7664	7665	a	a	DT	B-NP
O	7666	7671	locus	locus	NN	I-NP
O	7672	7682	containing	contain	VBG	B-VP
O	7683	7686	the	the	DT	B-NP
O	7687	7691	gene	gene	NN	I-NP
O	7692	7700	encoding	encode	VBG	B-VP
O	7701	7705	Igf2	Igf2	NN	B-NP
O	7706	7708	to	to	TO	B-PP
O	7709	7717	diabetes	diabetes	NN	B-NP
O	7718	7720	in	in	IN	B-PP
O	7721	7724	the	the	DT	B-NP
O	7725	7727	GK	GK	NN	I-NP
O	7728	7731	rat	rat	NN	I-NP
O	7732	7733	[	[	(	O
O	7733	7736	127	127	CD	B-NP
O	7736	7737	]	]	)	O
O	7737	7738	.	.	.	O

O	7739	7742	The	The	DT	B-NP
O	7743	7747	Igf2	Igf2	NN	I-NP
O	7748	7752	gene	gene	NN	I-NP
O	7753	7755	is	be	VBZ	B-VP
O	7756	7765	subjected	subject	VBN	I-VP
O	7766	7768	to	to	TO	B-PP
O	7769	7777	paternal	paternal	JJ	B-NP
O	7778	7785	genomic	genomic	JJ	I-NP
O	7786	7796	imprinting	imprinting	NN	I-NP
O	7796	7797	.	.	.	O

O	7798	7805	However	However	RB	B-ADVP
O	7805	7806	,	,	,	O
O	7807	7814	because	because	IN	B-SBAR
O	7815	7818	the	the	DT	B-NP
O	7819	7823	Igf2	Igf2	NN	I-NP
O	7824	7834	expression	expression	NN	I-NP
O	7835	7837	is	be	VBZ	B-VP
O	7838	7847	similarly	similarly	RB	I-VP
O	7848	7856	affected	affect	VBN	I-VP
O	7857	7859	in	in	IN	B-PP
B-Developing_anatomical_structure	7860	7867	fetuses	fetus	NNS	B-NP
O	7867	7868	,	,	,	O
O	7869	7879	regardless	regardless	RB	B-ADVP
O	7880	7882	of	of	IN	B-PP
O	7883	7890	whether	whether	IN	B-SBAR
O	7891	7894	the	the	DT	B-NP
O	7895	7901	father	father	NN	I-NP
O	7902	7904	is	be	VBZ	B-VP
O	7905	7906	W	W	NN	B-NP
O	7907	7909	or	or	CC	I-NP
O	7910	7912	GK	GK	NN	I-NP
O	7913	7914	[	[	(	O
O	7914	7916	87	87	CD	B-NP
O	7916	7917	]	]	)	O
O	7917	7918	,	,	,	O
O	7919	7921	we	we	PRP	B-NP
O	7922	7928	cannot	cannot	MD	B-VP
O	7929	7937	conclude	conclude	VB	I-VP
O	7938	7942	with	with	IN	B-PP
O	7943	7944	a	a	DT	B-NP
O	7945	7951	simple	simple	JJ	I-NP
O	7952	7958	change	change	NN	I-NP
O	7959	7961	of	of	IN	B-PP
O	7962	7966	Igf2	Igf2	NN	B-NP
O	7967	7971	gene	gene	NN	I-NP
O	7972	7982	imprinting	imprinting	NN	I-NP
O	7983	7985	in	in	IN	B-PP
O	7986	7989	the	the	DT	B-NP
O	7990	7992	GK	GK	NN	I-NP
O	7993	7996	rat	rat	NN	I-NP
O	7996	7997	.	.	.	O

O	7998	8005	Finally	Finally	RB	B-ADVP
O	8005	8006	,	,	,	O
O	8007	8010	our	our	PRP$	B-NP
O	8011	8024	understanding	understanding	NN	I-NP
O	8025	8027	of	of	IN	B-PP
O	8028	8031	the	the	DT	B-NP
O	8032	8042	underlying	underlie	VBG	I-NP
O	8043	8053	mechanisms	mechanism	NNS	I-NP
O	8054	8057	for	for	IN	B-PP
O	8058	8065	reduced	reduce	VBN	B-NP
O	8066	8069	BCM	BCM	NNS	I-NP
O	8070	8072	in	in	IN	B-PP
O	8073	8081	response	response	NN	B-NP
O	8082	8084	to	to	TO	B-PP
O	8085	8098	inappropriate	inappropriate	JJ	B-NP
O	8099	8108	perinatal	perinatal	JJ	I-NP
O	8109	8118	nutrition	nutrition	NN	I-NP
O	8119	8121	is	be	VBZ	B-VP
O	8122	8129	growing	grow	VBG	I-VP
O	8130	8137	rapidly	rapidly	RB	B-ADVP
O	8137	8138	.	.	.	O

O	8139	8146	However	However	RB	B-ADVP
O	8146	8147	,	,	,	O
O	8148	8151	the	the	DT	B-NP
O	8152	8160	relative	relative	JJ	I-NP
O	8161	8173	contribution	contribution	NN	I-NP
O	8174	8176	of	of	IN	B-PP
O	8177	8180	the	the	DT	B-NP
O	8181	8185	many	many	JJ	I-NP
O	8186	8195	intrinsic	intrinsic	JJ	I-NP
O	8196	8199	and	and	CC	I-NP
O	8200	8209	extrinsic	extrinsic	JJ	I-NP
O	8210	8217	factors	factor	NNS	I-NP
O	8218	8223	which	which	WDT	B-NP
O	8224	8234	contribute	contribute	VBP	B-VP
O	8235	8237	to	to	TO	B-PP
O	8238	8241	the	the	DT	B-NP
O	8242	8250	adaptive	adaptive	JJ	I-NP
O	8251	8259	response	response	NN	I-NP
O	8260	8262	of	of	IN	B-PP
O	8263	8266	the	the	DT	B-NP
O	8267	8277	developing	develop	VBG	I-NP
B-Organ	8278	8287	endocrine	endocrine	JJ	I-NP
I-Organ	8288	8296	pancreas	pancreas	NN	I-NP
O	8297	8299	is	be	VBZ	B-VP
O	8300	8305	still	still	RB	B-ADVP
O	8306	8308	to	to	TO	B-VP
O	8309	8311	be	be	VB	I-VP
O	8312	8323	established	establish	VBN	I-VP
O	8323	8324	.	.	.	O

